Your search returned 16194 results.

Results
	16161.	Role of the bone marrow microenvironment in multiple myeloma. [electronic resource] by Roodman, G David Producer: 20030424 In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16162.	Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. [electronic resource] by Bezzi, Manuela Hasmim, Meriem Bieler, Grégory Dormond, Olivier Rüegg, Curzio Producer: 20031224 In: The Journal of biological chemistry vol. 278 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16163.	Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. [electronic resource] by Voskaridou, Ersi Terpos, Evangelos Spina, Giovanna Palermos, John Rahemtulla, Amin Loutradi, Aphroditi Loukopoulos, Dimitris Producer: 20040105 In: British journal of haematology vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16164.	In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. [electronic resource] by Meraviglia, S Eberl, M Vermijlen, D Todaro, M Buccheri, S Cicero, G La Mendola, C Guggino, G D'Asaro, M Orlando, V Scarpa, F Roberts, A Caccamo, N Stassi, G Dieli, F Hayday, A C Producer: 20100827 In: Clinical and experimental immunology vol. 161 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16165.	Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways. [electronic resource] by Hasmim, M Bieler, G Rüegg, C Producer: 20070215 In: Journal of thrombosis and haemostasis : JTH vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16166.	Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase. [electronic resource] by Montalvetti, A Bailey, B N Martin, M B Severin, G W Oldfield, E Docampo, R Producer: 20011011 In: The Journal of biological chemistry vol. 276 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16167.	Effects of a bisphosphonate on the expression of bone specific genes after autogenous free bone grafting in rats. [electronic resource] by Myoung, H Park, J Y Choung, P H Producer: 20010906 In: Journal of periodontal research vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16168.	Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. [electronic resource] by Kimachi, Keiichiro Kajiya, Hiroshi Nakayama, Shuji Ikebe, Tetsuro Okabe, Koji Producer: 20110729 In: Naunyn-Schmiedeberg's archives of pharmacology vol. 383 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16169.	Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor? [electronic resource] by Bernasconi, Paolo Farina, Mirko Boni, Marina Dambruoso, Irene Calvello, Celeste Producer: 20160906 In: American journal of hematology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16170.	Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line. [electronic resource] by Fabbri, Francesco Brigliadori, Giovanni Carloni, Silvia Ulivi, Paola Vannini, Ivan Tesei, Anna Silvestrini, Rosella Amadori, Dino Zoli, Wainer Producer: 20080926 In: Journal of translational medicine vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16171.	Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. [electronic resource] by Katz, J Gong, Y Salmasinia, D Hou, W Burkley, B Ferreira, P Casanova, O Langaee, T Y Moreb, J S Producer: 20110927 In: International journal of oral and maxillofacial surgery vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16172.	Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells. [electronic resource] by Riganti, Chiara Castella, Barbara Kopecka, Joanna Campia, Ivana Coscia, Marta Pescarmona, Gianpiero Bosia, Amalia Ghigo, Dario Massaia, Massimo Producer: 20131022 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16173.	Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma. [electronic resource] by Salaroglio, Iris Chiara Campia, Ivana Kopecka, Joanna Gazzano, Elena Orecchia, Sara Ghigo, Dario Riganti, Chiara Producer: 20151127 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16174.	KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models. [electronic resource] by Kenessey, István Kói, Krisztina Horváth, Orsolya Cserepes, Mihály Molnár, Dávid Izsák, Vera Dobos, Judit Hegedűs, Balázs Tóvári, József Tímár, József Producer: 20180222 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16175.	Developments in the pharmacotherapeutic management of osteoporosis. [electronic resource] by Close, Pierre Neuprez, Audrey Reginster, Jean-Yves Producer: 20060818 In: Expert opinion on pharmacotherapy vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16176.	Isolation of mutant cells lacking Insig-1 through selection with SR-12813, an agent that stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. [electronic resource] by Sever, Navdar Lee, Peter C W Song, Bao-Liang Rawson, Robert B Debose-Boyd, Russell A Producer: 20041124 In: The Journal of biological chemistry vol. 279 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16177.	Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. [electronic resource] by Gordon, Leslie B Massaro, Joe D'Agostino, Ralph B Campbell, Susan E Brazier, Joan Brown, W Ted Kleinman, Monica E Kieran, Mark W Producer: 20140902 In: Circulation vol. 130 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16178.	Update in endocrinology: evidence published in 2012. [electronic resource] by Schlechte, Janet A Producer: 20130802 In: Annals of internal medicine vol. 158 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16179.	Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. [electronic resource] by Cui, Nianhui Nomura, Takeshi Noma, Hiroyasu Yokoo, Keiko Takagi, Ryo Hashimoto, Sadamitsu Okamoto, Masato Sato, Mitsunobu Yu, Guangyan Guo, Chuanbin Shibahala, Takahiko Producer: 20050808 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16180.	Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment. [electronic resource] by Efstathiou, E Bozas, G Kostakopoulos, A Kastritis, E Deliveliotis, C Antoniou, N Skarlos, D Papadimitriou, C Dimopoulos, M A Bamias, A Producer: 20050919 In: Urology vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 16194 results.